Author: Braus D.F. Ende G. Weber-Fahr W. Demirakca T. Tost H. Henn F.A.
Publisher: Elsevier
ISSN: 0924-977X
Source: European Neuropsychopharmacology, Vol.12, Iss.2, 2002-04, pp. : 145-152
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Guidelines for depot antipsychotic treatment in schizophrenia
By Kane J.M. Aguglia E. Altamura A.C. Gutierrez J.L.A. Brunello N. Fleischhacker W.W. Gaebel W. Gerlach J. Guelfi J.-D. Kissling W. Lapierre Y.D. Lindstrom E. Mendlewicz J. Racagni G. Carulla L.S. Schooler N.R.
European Neuropsychopharmacology, Vol. 8, Iss. 1, 1998-02 ,pp. :
Role of Antipsychotic Polypharmacotherapy in the Treatment of Schizophrenia
By Canales P.L.
CNS Drugs, Vol. 12, Iss. 3, 1999-09 ,pp. :
Pharmacogenetics of Antipsychotic Drugs in Schizophrenia Treatment
Current Psychopharmacology, Vol. 1, Iss. 1, 2012-02 ,pp. :